FDA Inspection 1015511 — Banco de Sangre ASEM

Banco de Sangre ASEM — FEI 3006710143

The FDA completed an inspection of Banco de Sangre ASEM on June 22, 2017 in San Juan, PR. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 22, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
San Juan, PR (United States)

Citations

IDCFRDescription
1803821 CFR 606.100(b)SOPs for investigations, records
922521 CFR 606.171Biological product deviation report
9821 CFR 606.100(c)Thorough investigations